FUSED IMIDAZOLES FOR CANCER TREATMENT

Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GORE, VIKAS, GEKELER, VOLKER, ZUELCH, ARMIN, ZIMMERMANN, ASTRID, BAER, THOMAS, JOSHI, HEMANT, MUNOT, YOGESH, S, SHIVATARE, SACHIN, S, BHISE, UMESH, HOELDER, SWEN, MAIER, THOMAS, CHAVAN, SUNIL, BECKERS, THOMAS, PATEL, SARVESH, A
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.